Peptide-based covalent inhibitors of protein-protein interactions

被引:22
|
作者
Paulussen, Felix M. [1 ,2 ,3 ]
Grossmann, Tom N. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci AIMMS, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Dept Mol Microbiol, Amsterdam, Netherlands
基金
欧盟地平线“2020”;
关键词
bioconjugation; new modalities; peptidomimetics; proteomimetics; structure-based design; STRUCTURE-BASED DESIGN; CONSTRAINED PEPTIDES; HELICAL PEPTIDES; BH3; HELIX; SUPPRESSOR; MODULATORS; BFL-1; CHALLENGES; INSIGHTS; CYSTEINE;
D O I
10.1002/psc.3457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein-protein interactions (PPI) are involved in all cellular processes and many represent attractive therapeutic targets. However, the frequently rather flat and large interaction areas render the identification of small molecular PPI inhibitors very challenging. As an alternative, peptide interaction motifs derived from a PPI interface can serve as starting points for the development of inhibitors. However, certain proteins remain challenging targets when applying inhibitors with a competitive mode of action. For that reason, peptide-based ligands with an irreversible binding mode have gained attention in recent years. This review summarizes examples of covalent inhibitors that employ peptidic binders and have been tested in a biological context.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Thermodynamics of protein-protein and peptide interactions
    Cooper, A
    SELF-ASSEMBLING PEPTIDE SYSTEMS IN BIOLOGY, MEDICINE AND ENGINEERING, 2001, : 47 - 64
  • [22] Protein-protein interactions: Mimics and inhibitors
    Chmielewski, J
    BIOPOLYMERS, 1998, 47 (04) : 263 - 263
  • [23] β-Peptides as inhibitors of protein-protein interactions
    Kritzer, JA
    Stephens, OM
    Guarracino, DA
    Reznik, SK
    Schepartz, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (01) : 11 - 16
  • [24] Peptide inhibitors targeting Ras and Ras-associated protein-protein interactions
    Han, Dan
    Li, Anpeng
    Zhu, Lie
    Zhuang, Chunlin
    Zhao, Qingjie
    Zou, Yan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 279
  • [25] Assessing the cellular toxicity of peptide inhibitors of intracellular protein-protein interactions by microinjection
    Reddiar, Sanjeevini Babu
    Al-Wassiti, Hareth
    Pouton, Colin W.
    Nowell, Cameron J.
    Matthews, Macgregor A.
    Rahman, Arfatur
    Barlow, Nicholas
    Norton, Raymond S.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 29
  • [26] Turning Peptide Ligands into Small-Molecule Inhibitors of Protein-Protein Interactions
    Hashimoto, Chie
    Eichler, Jutta
    CHEMBIOCHEM, 2015, 16 (13) : 1855 - 1856
  • [27] SMALL PEPTIDE INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS IN JAK-STAT PATHWAY
    Aiello, C.
    Scognamiglio, P. L.
    Grieco, P.
    Marasco, D.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S243 - S244
  • [28] Potent inhibitors of LXXLL-based protein-protein interactions
    Galande, AK
    Bramlett, KS
    Trent, JO
    Burris, TP
    Wittliff, JL
    Spatola, AF
    CHEMBIOCHEM, 2005, 6 (11) : 1991 - 1998
  • [29] Peptide design to control protein-protein interactions
    van Wier, Suzanne P.
    Beekman, Andrew M.
    CHEMICAL SOCIETY REVIEWS, 2025, 54 (04) : 1684 - 1698
  • [30] Inhibitors of protein-protein interactions as potential drugs
    Veselovsky, Alexander V.
    Archakov, Alexander I.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (01) : 51 - 58